| Autor: |
Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Petkovic M; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany., Elizalde S; Department of Mathematics, Dartmouth College, Hanover, NH, USA., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Dewhurst SM; Laboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA., Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Human Genetics, University of Leuven, Leuven, Belgium., Dentro SC; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Oxford Big Data Institute, University of Oxford, Oxford, UK.; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Au L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Escudero M; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Bakir MA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Xu H; Stanford Cancer Institute, Stanford, CA, USA., Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Mourikis TP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK., Spain L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Cresswell GD; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK., Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Lamy P; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark., Nordentoft I; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark., Harbst K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden., Castro-Giner F; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Yates LR; Wellcome Trust Sanger Institute, Hinxton, UK.; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Caramia F; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Jaulin F; INSERM U1279, Gustave Roussy, Villejuif, France., Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France., Tomlinson IPM; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK., Brastianos PK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Cho RJ; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Bastian BC; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Dyrskjøt L; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark., Jönsson GB; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden., Savas P; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Loi S; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, UK., Andre F; INSERM U981, PRISM Institute, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Medical School, Université Paris Saclay, Kremlin Bicetre, France., Luscombe NM; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; UCL Genetics Institute, Department of Genetics, Evolution & Environment, University College London, London, UK.; Okinawa Institute of Science & Technology, Okinawa, Japan., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, School of GROW, Maastricht University Medical Center, Maastricht, The Netherlands., Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; 2nd Department of Pathology, SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary., Turajlic S; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schwarz RF; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. roland.schwarz@mdc-berlin.de., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk. |
Full text from SpringerLink